Author: Juan Luis Serrano Leets
Pathways to extend the term of pharmaceutical patents in Mexico
A combination of regulatory developments and recent judicial criteria have opened different avenues to adjust the duration of exclusivity periods. In recent years, substantial changes have been made to the Intellectual Property System in Mexico, creating the possibility of modifying the term of patents related to pharmaceutical products. In this entry, we analyze three relevant […]
The Complex Protection of New Pharmaceutical Products in Mexico
The absence of specific regulations makes it difficult to defend the exclusivity period granted to pharmaceutical companies over the clinical trial results that allow new drugs to be brought to market. Pharmaceutical companies operating in Europe and the United States are very familiar with the concept of regulatory data exclusivity, which the European Medicines Agency […]